Zydus FDA Monday, January 31, 2011 0.00 Neutral

FDA Approves GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Zydus Pharmaceuticals USA Inc.

Zydus Pharmaceuticals USA Inc. received final FDA approval today for the age-restricted immediate-release tablets of glipizide and metformin hydrochloride under ANDA 078905. This clearance expands the availability of a widely used oral diabetic therapy for patients aged 10 to 17, creating new market segmentation opportunities for Zydus amid heightened demand for pediatric oral diabetes care.

View original filing at SEC.gov →

AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed